• Neuromancer@lemm.eeOPM
        link
        fedilink
        arrow-up
        1
        arrow-down
        6
        ·
        7 months ago

        No, I think we should limit the cost of drugs based solely on cost to manufacture and distribute, and pay those operational costs

        If we payed for the research. I agree. Otherwise companies will just spend less on research. I don’t mind capping margins unless they don’t enforce the patent.